Victoria Vakiener - 10 Jan 2023 Form 4 Insider Report for ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Role: Director
Signature: /s/Victoria Vakiener
Issuer symbol: ARWR
Transactions as of: 10 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 11 Jan 2023, 19:35:29 UTC
Previous filing: 24 Jun 2022
Next filing: 12 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARWR	Common Stock	Disposed to Issuer	$0	-1,764	-10%	$0.000000	15,417	10 Jan 2023	Direct	F1
transaction	ARWR	Common Stock	Award	$0	+7,867	+51%	$0.000000	23,284	10 Jan 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARWR	Common Stock	Award	$0	+4,593		$0.000000	4,593	10 Jan 2023	Common Stock	4,593	$33.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Correction to previously granted award from 17,181 to 15,417.
F2	Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
F3	Includes a total of 15,417 shares underlying restricted stock units, which vest over three years.
F4	Represents options, which will vest in one installment on the first anniversary of the grant date.